NCT01942889

Brief Summary

On the basis of published data and investigators results indicating that systemic redox in balance may contribute to the peripheral muscle dysfunction in COPD patients, the investigators propose a study testing the effects of antioxidants and exercise training in COPD patients. The results may have major implication in the improvement of pulmonary rehabilitation benefits

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Apr 2012

Typical duration for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 14, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 16, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

August 16, 2018

Status Verified

August 1, 2018

Enrollment Period

2.7 years

First QC Date

August 14, 2013

Last Update Submit

August 14, 2018

Conditions

Keywords

COPDexercise trainingpulmonary rehabilitationantioxidantmuscle

Outcome Measures

Primary Outcomes (1)

  • quadriceps endurance time.Time frame: at the start and the end of the study

    sitting on a bench, starting from a 90° knee flexion of the dominant leg, the subjects should perform knee extensions (6 movements per minute) with a workload to 30% of the isometric maximal voluntary contraction until exhaustion. The duration of the test (in seconds) characterizes the quadriceps endurance.

    up to day 37

Secondary Outcomes (2)

  • muscle and /or serum oxidative stress level

    up to day 37

  • Isometric maximal voluntary contraction of the quadriceps

    up to day 37

Study Arms (2)

Antioxidant Supplementation

ACTIVE COMPARATOR

Vitamin antioxidant and trace elements combination that won't exceed the maximal nutritional dose recommended in France (Vit E, vit C, Selenomethionine, Zinc gluconate).

Dietary Supplement: Antioxidant Supplementation associated to Comprehensive respiratory Rehabilitation Program

Placebo

PLACEBO COMPARATOR

Placebo

Dietary Supplement: Antioxidant Supplementation associated to Comprehensive respiratory Rehabilitation Program

Interventions

Vit E, Vit C, Selenomethionine, Zinc gluconate

Antioxidant SupplementationPlacebo

Eligibility Criteria

Age40 Years - 78 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD patients, 40 years to 78 years, last exacerbation dating at least 4 weeks

You may not qualify if:

  • unstabilized primary pathologies (cardiovascular, renal, metabolic, psychiatric)
  • nutritional supplementation in the 4 weeks preceding the study (antioxidant, vitamins…)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinique du souffle la vallonie

Lodève, 34700, France

Location

University Hospital of Montpellier

Montpellier, 34295, France

Location

Related Publications (1)

  • Gouzi F, Maury J, Heraud N, Molinari N, Bertet H, Ayoub B, Blaquiere M, Bughin F, De Rigal P, Poulain M, Pincemail J, Cristol JP, Laoudj-Chenivesse D, Mercier J, Prefaut C, Pomies P, Hayot M. Additional Effects of Nutritional Antioxidant Supplementation on Peripheral Muscle during Pulmonary Rehabilitation in COPD Patients: A Randomized Controlled Trial. Oxid Med Cell Longev. 2019 Apr 17;2019:5496346. doi: 10.1155/2019/5496346. eCollection 2019.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2013

First Posted

September 16, 2013

Study Start

April 1, 2012

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

August 16, 2018

Record last verified: 2018-08

Locations